December 18, 2024 - 13:43

A former New York City real estate finance executive pleaded guilty Tuesday to charges of drugging and sexually assaulting a teenage girl over an extended period. The man, whose identity has not been disclosed, faced serious allegations that detailed a pattern of predatory behavior. Prosecutors revealed that the assaults occurred multiple times, with the victim being incapacitated through the administration of drugs.
The case has drawn significant attention due to the position of the accused, highlighting concerns about the abuse of power and trust in society. As part of the plea agreement, he is expected to face substantial prison time. The victim's courage in coming forward has been commended, as it sheds light on the critical issue of sexual violence and the importance of supporting survivors.
This case serves as a stark reminder of the ongoing challenges in addressing sexual assault and the need for systemic changes to protect vulnerable individuals from similar predatory actions in the future.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...